CO-OPTIV-SECURITY
3.6.2019 20:07:03 CEST | Business Wire | Press release
While industries are being completely reinvented at an ever-accelerating pace, the overall approach to cybersecurity has not similarly evolved to address the new security challenges presented by rapid digital transformation. Talent shortages, expanding attack surfaces, and constant breaches are all symptoms of an unnecessarily complex and inefficiently constructed cybersecurity world. Optiv Security , a global cybersecurity integrator delivering end-to-end cybersecurity solutions, today announced it has implemented a new cybersecurity services approach, business and engagement model that transforms the way cybersecurity is consumed and applied. Optiv’s innovative approach is specifically designed to deliver to organizations integrated cybersecurity solutions that address the speed of business change, by providing new consumption and outcome-based consulting services and cybersecurity solutions that ultimately achieve higher performance and reduced overall operational costs.
Specifically, the company is launching the following to more tightly align its breadth of capabilities and client-centric approach, to bring to market more focused global cybersecurity solutions that encompass people, process and technology.
- Newly launched Global Services and Operations Organization – Optiv has redesigned its services approach centered on client-focused outcomes and is delivering global capabilities to assist clients along their cybersecurity journeys. The company’s breadth of services addresses the full lifecycle of client security needs – with newly launched business lines for Advisory, Integration & Innovation, and CyberOperations - providing global clients with the required focus and scale to execute on full end-to-end cyber risk, cyber digital and cybersecurity projects and programs.
-
Cyber-as-a-Service (CaaS
TM
) Platform
–
designed to ensure organizations benefit from fully-integrated
solutions that scale on-demand with business needs and automatically
adapt to shifting business requirements. This approach enables Optiv
to deliver complex and integrated solutions with an innovative
integrated technology stack focused on client outcomes. Optiv’s new
CaaSTM
offerings can be consumed alone, or combined with
Optiv’s advisory, integration or managed services to harden security
fundamentals across four critical areas of modern business risk:
- Risk management and compliance, including resilience and assurance;
- Cyber digital transformation, including cloud, orchestration, automation and big data;
- Threat management, including protection, detection and response; and
- Identity and data management.
- Global Services Demand (GSD) Organization – Coordinating Partner and Teaming Delivery Model – Optiv created GSD to provide clients with the optimal mix of centralized oversight and buying power, and localized technical resources and expertise. This new engagement model also brings together a seasoned team of regionally-focused senior technical services executives to give clients an important engagement layer atop Optiv’s more than 1,300 deeply skilled and specialized cybersecurity delivery practitioners. These executives serve as global coordinating partners for our clients, acting as a single point of accountability to drive excellence for complex end-to-end cybersecurity services and solutions.
“After more than 40 years since the first virus was launched, the approach to addressing cybersecurity issues has followed the same action and response formula. The challenge is that the world has changed, while the approach to cybersecurity has not kept pace,” said Chad Holmes, chief services and operations officer. “Industries are being completely reinvented – through digital transformation, cloud and data models, Artificial Intelligence (AI), globalization and much more – while cybersecurity gaps expand as symptoms of a historical approach to a new and different business model.”
Holmes continued, “Our new Cyber-as-a-Service consumption model, which we are launching based on client feedback and to meet growing market demand, strongly complements our traditional services model. It enables clients to have a choice in their cybersecurity consumption model, and thereby transform their organizational cybersecurity approach, while benefiting from the same cloud economics that have been used to transform entire industries. This custom developed, innovative and integrated approach provides organizations with increased flexibility and choice in how they procure cybersecurity – from standalone tools to integrated solutions – addressing complex security problems and delivering better alignment to unique business requirements. Optiv is extremely excited to bring to market our new Cyber-as-a-Service, integrated business services and client engagement models, that will increase our ability to provide clients with the right global resources at the right time so that we can truly serve their best interests.”
Please visit our website for more information about our cybersecurity solutions and capabilities.
Follow Optiv
Twitter: www.twitter.com/optiv
LinkedIn:
www.linkedin.com/company/optiv-inc
Facebook:
www.facebook.com/optivinc
YouTube:
https://www.youtube.com/c/OptivInc
Blog:
www.optiv.com/resources/blog
About Optiv Security
Optiv is a global cybersecurity solutions integrator – a “one-stop” trusted partner with a singular focus on cybersecurity. Our end-to-end cybersecurity capabilities span risk management and transformation, cyber digital transformation, threat management, cyber operations, identity and data management, and integration and innovation, helping organizations realize stronger, simpler and more cost-efficient cybersecurity programs that support business requirements and outcomes. At Optiv, we are modernizing cybersecurity to enable clients to innovate their consumption models, integrate infrastructure and technology to maximize value, achieve measurable outcomes, and realize complete solutions and business alignment. For more information about Optiv, please visit us at www.optiv.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190603005657/en/
Contact:
Jason Cook (816) 701-3374 Jason.cook@optiv.com or Brett Ater (913) 304-7683 Brett.ater@optiv.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
